RT Journal Article
SR Electronic
T1 Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8<sup>+</sup> T cells
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006611
DO 10.1136/jitc-2022-006611
VO 11
IS 6
A1 LaPorte, Kathryn M
A1 Hernandez, Rosmely
A1 Santos Savio, Alicia
A1 Malek, Thomas R
YR 2023
UL http://jitc.bmj.com/content/11/6/e006611.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.